Citigroup’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.56K | Sell |
|
|||||
|
2025
Q1 | $34.7K | Sell |
|
|||||
|
2024
Q4 | $112K | Buy |
|
|||||
|
2024
Q3 | $197K | Buy |
|
|||||
|
2024
Q2 | $52.1K | Buy |
|
|||||
|
2024
Q1 | $69.2K | Buy |
|
|||||
|
2023
Q4 | $28.7K | Buy |
|
|||||
|
2023
Q3 | $75 | Sell |
|
|||||
|
2023
Q2 | $56.1K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $51K | Buy |
|
|||||
|
2021
Q4 | $25K | Buy |
|
|||||
|
2021
Q3 | $36K | Buy |
|
|||||
|
2021
Q2 | $36K | Buy |
|
|||||
|
2021
Q1 | $25K | Sell |
|
|||||
|
2020
Q4 | $46K | Buy |
|
|||||
|
2020
Q3 | $10K | Buy |
|